USPTO serial 90535983
COLLAFILM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 25, 2022
- Examiner
- COHEN, ROBERT ANDREW
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with COLLAFILM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Innocoll Pharmaceuticals Limited
Althone, Co. Roscommon, IE
Innocoll Pharmaceuticals Limited
Althone, Co. Roscommon, IE
Innocoll Pharmaceuticals Limited
Althone, Co. Roscommon, IE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Camille M. Miller
Camille M. Miller COZEN O'CONNOR1650 MARKET STREETSUITE 2800PHILADELPHIA, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, veterinary and sanitary preparations for the treatment of wounds, burns during surgery; medicated antibiotic creams, medicated antibiotic lotions, medicated antibiotic gels for medical use in or on the human and non-human animal body; Dressings, foils, compresses, wadding, foams, semi-liquid matrice, barriers, all being medical dressings, bandages for skin wounds, sponges impregnated with antiseptics, and all for medical use in or on the human and non-human animal body; Medicated creams, medicated lotions, medicated gels featuring collagen for treating skin wounds and burns; Collagen dressings, foils, medicated compresses, wadding, foams, semi-liquid matrices all being medical dressings; Medicated analgesic creams, medicated analgesic lotions, medicated analgesic gels, dressings, foils, compresses, wadding, foams, semi-liquid matrice, barriers, all being medical dressings, bandages for skin wounds, sponges impregnated with antiseptics all for topical use; surgical implants comprised of living tissues for use in skin repair and skin improvement; surgical and medical implants composed of living collagen; surgical implants comprised of living collagen for wound management and pain relief; Suspensory medical dressings; Supportive medical dressings; Suspensory and supportive medical film dressings | ACTIVE | — |
| 010 | Surgical compresses; Surgical implants comprised of artificial materials, Surgical membrane implants comprised of artificial materials; Surgical sponges; Surgical and medical drug delivery patches sold without medication for use in skin repair and skin improvement; Surgical implants comprising artificial material for use in skin repair and skin improvement; ; Surgical and medical drug delivery patches sold without medication for use in skin repair and skin improvement; Surgical and medical implant devices composed of artificial collagen; Artificial collagen constructs for medical, surgical or veterinary purposes being an implant; Surgical implants comprised of artificial collagen for management of post-operative pain; Surgical implants comprised of artificial collagen for wound management | ACTIVE | — |
| 042 | Medical and scientific research services in the field of collagen based drug delivery systems; medical and scientific research services for medical, veterinary and pharmaceutical purposes, scientific research in the fields of chemistry and biochemistry; Scientific research consultancy services relating to the development of medical and surgical products; Scientific research services for others performed on a temporary contract basis in the field of collagen based drug delivery systems; Scientific research and development of medical and surgical products for others, Laboratory scientific research services relating to operational testing of medical and surgical products; Analysis of technical data for others, namely, analysis of collagen for research purposes relating to pharmaceuticals for humans and animals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Innocoll Pharmaceuticals Limited
- Other trademarks owned by Innocoll Pharmaceuticals Limited
- Other trademarks owned by Innocoll Pharmaceuticals Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named COLLAFILM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 8, 2023 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jan 25, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 20, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 1, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 1, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 1, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 1, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 15, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 13, 2021 | ALIE | ASSIGNED TO LIE | — |
| Sep 3, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 2, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 2, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 2, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 27, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 20, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 23, 2021 | NWAP | NEW APPLICATION ENTERED | — |